Delivery Order SPE2DB20D3101-SPE2DB24FRPP4

Award Date 7/9/24
Potential Completion Date 7/10/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,786.63, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4563284246 units of Insulin Lispro 100 Unit/mL Vial 10mL. The contract has a firm fixed price and an ultimate completion date of January 10, 2024. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor for federal healthcare programs, particularly within...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,410.24 delivery order contract is for the supply of Insulin Lispro 100 Unit/mL Pen 3mL, a critical medication for diabetes management. The contract has an ultimate completion date of October 24, 2022 and is a firm fixed-price delivery order. This award is associated with AmerisourceBergen's larger $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,375.44 firm fixed-price delivery order is for the supply of insulin lispro 100 unit/mL pens. The contract has an ultimate completion date of January 24, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award is for the delivery of INSULIN LISPRO 100 UNIT/ML VL 10ML, awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,003.77 firm fixed-price delivery order contract has an ultimate completion date of December 16, 2024. It is not designated as a set-aside contract. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is for the delivery of insulin lispro 100 unit/ml vials (10 ml) to the Defense Logistics Agency (DLA) by the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a ceiling value of $1,916.29 and was awarded on October 27, 2021 with an ultimate completion date of October 28, 2021. This is a delivery order contract with a firm fixed price pricing type. The contract is not designated with any set-aside requirements, indicating...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,664.12 firm fixed-price delivery order is for the supply of Humalog 100 unit/mL vial, a 10 mL insulin medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, which provides a comprehensive range of...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of Insulin Lispro 100 unit/mL Pen 3mL. The contract has a firm fixed price of $1,529.48 and a completion date of May 16, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a comprehensive range of medical commodities to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,501.12 firm fixed-price delivery order is for the supply of 4565927956 - INSULIN LISPRO 100 UNIT/ML PEN 3ML, with a final completion date of September 25, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $1,048.14, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of Insulin Lispro 100 Unit/mL Pens, a critical medication for diabetes management. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,641.34, is for the delivery of 4564186129 Insulin Aspart 100 Unit/mL Vial 10mL. The contract has a firm fixed price and an ultimate completion date of April 8, 2024. The contract is a delivery order and was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRPP4
    Delivery Order

This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,275.48, is for the delivery of Insulin Lispro 100 Unit/mL Vials (10 mL) to support military healthcare programs. The contract has a firm fixed price and a completion date of July 10, 2024.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 2/27/25, 11:29 AM